The present invention is related to a method for treating an ocular disease, particularly a diabetes related ocular disease, comprising administering to a subject in need thereof an effective amount of a group of compounds having a structure of Formula A1, wherein the ocular disease is selected from the group consisting of proliferative vitreoretinopathy (PVR), uveitis, glaucoma and age related macular degeneration (AMD), and the diabetes related ocular disease is selected from the group consisting of diabetic retinopathy (DR) and diabetic macular edema (DME).本發明有關於一種用於治療眼疾的方法，具體而言是一種治療糖尿病相關的眼疾的方法，該方法包含向有其需要的個體投予有效量的具有式A1結構的一組化合物，其中眼疾係選自由增生性玻璃體視網膜病變、葡萄膜炎、青光眼及老年性黃斑病變所組成的群組，且糖尿病相關的眼疾係選自由糖尿病視網膜病變及糖尿病黃斑水腫所組成的群組。
